| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |